FDA grants ABK Biomedical a breakthrough device designation for its proposed Eye90 microspheres and its use in treating patients living with unresecta...
FDAs Oncology Center of Excellence and real-world evidence company Syapse renew a four-year agreement to collaboratively develop and implement specifi...
FDA clears a West Pharmaceutical Services 510(k) for its Vial2Bag Advanced 13mm admixture device.
FDA issues a clinical hold on a Genentech multiple sclerosis clinical development program for fenebrutinib due to liver injury concerns.
FDA warns that it is continuing to advance its compliance activities associated with required clinical trial information postings in the ClinicalTrial...
FDA grants Eli Lilly accelerated approval for Jaypirca (pirtobrutinib) 100 mg & 50 mg tablets for treating certain adult patients with chronic lymphoc...
University researchers say there is a pressing need to explore alternative methods for inspecting overseas and domestic drug manufacturing facilities ...
Federal Register notice: FDA announces that it has issued a priority review voucher to Genzyme after gaining a qualified approval for Xenpozyme (olipu...
